About Visana Health
Visana Health is a private company based in Minneapolis, Minnesota. It has reported $45,667,580 raised in seven offerings on Form D since August 2019. Its chief executive is Joseph Connolly.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 10, 2026 | Apr 27, 2026 | $20,300fully sold | 1 | $20,300 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 1, 2025 | Aug 18, 2025 | $23,677,424fully sold | 10 | $2.3M | EquityRule 506(b) | Form D ↗ |
| Oct 18, 2024 | Nov 4, 2024 | $6,000,000fully sold | 7 | $857K | Debt, Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversionRule 506(b) | Form D ↗ |
| Jun 15, 2023 | Jun 30, 2023 | $125,000of $350K target | 3 | $41,667 | Debt, Promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversionRule 506(b) | Form D ↗ |
| May 25, 2023 | Jun 9, 2023 | $13,364,856fully sold | 18 | $742K | EquityRule 506(b) | Form D ↗ |
| Feb 3, 2022 | Feb 17, 2022amended Apr 20, 2022 | $2,350,000of $2.6M target | 9 | $261K | Debt, Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversionRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 19, 2019 | Aug 5, 2019 | $130,000of $500K target | 2 | $65,000 | Debt, Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversionRule 506(b) | Form D ↗ |
| Total, seven offerings | $45,667,580 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Visana Health's Form D filed Apr 27, 2026.
CT
OC
Olivia Capra
Director
MT
Michael Tudeen
Director
CP
MM
Margaret Malone
Director
CR
TM
SM
Spence McClelland
Director
Earlier filings also listed Scib Ebel (executive officer, last listed Aug 2025).